Vanguard Group’s Pliant Therapeutics PLRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.48M | Sell |
3,002,348
-332,227
| -10% | -$385K | ﹤0.01% | 3331 |
|
|
2025
Q1 | $4.5M | Buy |
3,334,575
+105,820
| +3% | +$143K | ﹤0.01% | 3220 |
|
|
2024
Q4 | $42.5M | Sell |
3,228,755
-297,759
| -8% | -$3.92M | ﹤0.01% | 2233 |
|
|
2024
Q3 | $39.5M | Buy |
3,526,514
+89,354
| +3% | +$1M | ﹤0.01% | 2281 |
|
|
2024
Q2 | $36.9M | Sell |
3,437,160
-41,195
| -1% | -$443K | ﹤0.01% | 2269 |
|
|
2024
Q1 | $51.8M | Buy |
3,478,355
+412,486
| +13% | +$6.15M | ﹤0.01% | 2150 |
|
|
2023
Q4 | $55.5M | Buy |
3,065,869
+120,557
| +4% | +$2.18M | ﹤0.01% | 2143 |
|
|
2023
Q3 | $51.1M | Buy |
2,945,312
+168,454
| +6% | +$2.92M | ﹤0.01% | 2128 |
|
|
2023
Q2 | $50.3M | Buy |
2,776,858
+404,136
| +17% | +$7.32M | ﹤0.01% | 2182 |
|
|
2023
Q1 | $63.1M | Buy |
2,372,722
+423,678
| +22% | +$11.3M | ﹤0.01% | 2061 |
|
|
2022
Q4 | $37.7M | Buy |
1,949,044
+349,720
| +22% | +$6.76M | ﹤0.01% | 2323 |
|
|
2022
Q3 | $33.4M | Buy |
1,599,324
+546,638
| +52% | +$11.4M | ﹤0.01% | 2382 |
|
|
2022
Q2 | $8.43M | Sell |
1,052,686
-180,013
| -15% | -$1.44M | ﹤0.01% | 3085 |
|
|
2022
Q1 | $8.64M | Buy |
1,232,699
+14,289
| +1% | +$100K | ﹤0.01% | 3233 |
|
|
2021
Q4 | $16.4M | Sell |
1,218,410
-200,189
| -14% | -$2.7M | ﹤0.01% | 2946 |
|
|
2021
Q3 | $23.9M | Buy |
1,418,599
+146,943
| +12% | +$2.48M | ﹤0.01% | 2758 |
|
|
2021
Q2 | $37M | Buy |
1,271,656
+168,971
| +15% | +$4.92M | ﹤0.01% | 2527 |
|
|
2021
Q1 | $43.4M | Buy |
1,102,685
+595,726
| +118% | +$23.4M | ﹤0.01% | 2395 |
|
|
2020
Q4 | $11.5M | Buy |
506,959
+65,966
| +15% | +$1.5M | ﹤0.01% | 2922 |
|
|
2020
Q3 | $9.99M | Buy |
440,993
+415,993
| +1,664% | +$9.42M | ﹤0.01% | 2791 |
|
|
2020
Q2 | $812K | Buy |
+25,000
| New | +$812K | ﹤0.01% | 3656 |
|